Goldman Sachs Maintains Buy on Sterling Check, Lowers Price Target to $18
Goldman Sachs analyst George Tong maintains Sterling Check (NASDAQ:STER) with a Buy and lowers the price target from $20 to $18.
Earnings Scheduled For March 2, 2023
Companies Reporting Before The Bell
• argenx (NASDAQ:ARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
The Latest Analyst Ratings for Sterling Check
Analysts have provided the following ratings for Sterling Check (NASDAQ:STER) within the last quarter: Bullish Somewhat Bullish Indifferent…
Goldman Sachs Maintains Buy on Sterling Check, Raises Price Target to $20
Goldman Sachs analyst George Tong maintains Sterling Check (NASDAQ:STER) with a Buy and raises the price target from $18 to $20.
8 Analysts Have This to Say About Sterling Check
Analysts have provided the following ratings for Sterling Check (NASDAQ:STER) within the last quarter:
Goldman Sachs Maintains Buy on Sterling Check, Lowers Price Target to $18
Goldman Sachs analyst George Tong maintains Sterling Check (NASDAQ:STER) with a Buy and lowers the price target from $21 to $18.